Skip Navigation


Back to EHJ: My Cardio Interviews

Colin Baigent in conversation with Thomas Lüscher:
SHARP: Cholesterol-lowering effective in kidney disease. (Feb 2011)

John P. Kastelein in conversation with Ulf Landmesser:
Epidemiology of HDL . (Feb 2011)

Stephen Nicholls in conversation with Ulf Landmesser
Results of the First Major Clinical Trial of an Oral Agent Inducing Apo A1 Synthesis: A New Approach to HDL Raising and CVR Risk Modification. (Nov 2010)

Peter Kowey in conversation with Ulf Landmesser
Efficacy and Safety of Prescription Omega-3-Acid Ethyl Esters (P-OM3) for the Prevention of Recurrent Symptomatic Atrial Fibrillation. (Nov 2010)

Back to top of page